Waymo’s latest funding round boosts it to a $45B valuation

Date:

Share post:


Waymo recently closed a $5.6 billion Series C funding round led by parent company Alphabet and joined by a who’s who of Silicon Valley venture firms. The investment boosts Waymo’s overall valuation to more than $45 billion, according to Bloomberg News.

Alphabet had previously announced in July that it was pledging another $5 billion to Waymo, but was mum on the specifics, saying only that it was a “multi-year” commitment. Andreesen Horowitz, Silver Lake, Fidelity, Tiger Global, Perry Creek, and T. Rowe Price all joined the round. Waymo declined to say how much each invested.

It’s Waymo’s second external fundraising round, and its first since a $2.25 billion Series B in 2020 that eventually grew to $3.2 billion. The autonomous vehicle company says it will use the funds to expand into new cities and further develop its autonomous capabilities for “business applications.”

Waymo is in some ways a much different company now than it was when it raised that last round. At that time, the company was still plowing headlong into an autonomous trucking effort that it has since pulled back from.

The company has instead put nearly its entire focus on its robotaxi ride-hailing service. The bet has paid off. Waymo now operates commercial robotaxi services in San Francisco, Los Angeles, Phoenix, and is expanding to Austin and Atlanta. It’s giving paid rides to more than 100,000 customers per week across those first three markets and offering trips to and from the airport in Phoenix. And it’s operating on highways in the Phoenix and San Francisco areas.

This story has been updated to include Waymo’s new reported valuation following the announcement of the funding.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

OpenAI’s GPT-5 reportedly falling short of expectations

OpenAI’s efforts to develop its next major model, GPT-5, are running behind schedule, with results that don’t...

OpenAI announces new o3 model — but you can’t use it yet

Welcome back to Week in Review. This week, we’re looking at OpenAI’s last — and biggest —...

Google pushes back against DOJ’s ‘interventionist’ remedies in antitrust case

Google has offered up its own proposal in a recent antitrust case that saw the US Department...

If climate tech is dead, what comes next?

Humans have an innate desire to name things, but to be honest, we’re not always that good...

Hollywood angels: Here are the celebrities who are also star VCs

Becoming a venture capitalist has become the latest status symbol in Hollywood.  Everyone these days, from Olivia Wilde...

Meet Skyseed, a VC fund and incubator backing the Bluesky and AT Protocol ecosystem

On November 15, Peter Wang posted a message requesting ideas for a new incubator and fund to...

Sam Altman disputes Marc Andreessen’s description of AI meetings with Biden administration

Famed investor Marc Andreessen recently talked about meetings with Biden administration staff who gave him the impression...

EV startup Canoo places remaining employees on a ‘mandatory unpaid break’

Struggling electric van startup Canoo has placed its remaining employees on what it’s calling a “mandatory unpaid...